United States Obesity Drugs Market Growth, Demand and Challenges of the Key Industry Players 2024-2032

1
United States Obesity Drugs Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "United States Obesity Drugs Market
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the United States
  obesity drugs market size is projected to exhibit
  a growth rate (CAGR) of 18.3 during 2024-2032.
• Obesity drugs, also known as weight-loss
  medications, are pharmaceutical substances
  designed to aid in weight reduction for
  individuals struggling with obesity or overweight
  conditions. These drugs work through various
  mechanisms, such as appetite suppression,
  interference with nutrient absorption, or
  increasing metabolism. While they can be
  effective when used alongside a comprehensive
  weight-loss program that includes dietary changes
  and exercise, they are not a standalone solution.
  
• Obesity drugs are typically prescribed for
  individuals with a body mass index (BMI) above 30
  or those with a BMI above 27 who have
  obesity-related health issues, such as type 2
  diabetes or high blood pressure. It is essential
  to use these medications under the supervision of
  a healthcare professional, as they may have side
  effects and interactions with other medications.
  Additionally, lifestyle changes should remain the
  cornerstone of any weight-loss effort.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/united-states-obesity-d
  rugs-market/requestsample

4
Report Description

• United States Obesity Drugs Market Trends
• The increasing prevalence of obesity in the
  United States is a primary driver. With more than
  one-third of adults classified as obese, there is
  a growing need for effective treatments to combat
  this epidemic. Additionally, greater awareness
  about the health risks associated with obesity
  has led to increased demand for weight management
  solutions. Healthcare professionals are actively
  educating patients about the benefits of obesity
  drugs in conjunction with lifestyle
  modifications. Other than this, shifts in
  lifestyle and dietary patterns, characterized by
  sedentary behavior and the consumption of
  calorie-dense foods, contribute to the obesity
  epidemic.
• As individuals struggle to maintain healthy
  weights, there is a heightened demand for
  interventions such as obesity drugs to assist in
  weight management. Besides this, despite concerns
  about healthcare costs, the willingness of
  consumers to spend on treatments for chronic
  conditions such as obesity remains high. With
  healthcare expenditure continuing to rise, there
  is significant market potential for obesity
  drugs. In line with this, the aging population in
  the United States is more susceptible to obesity
  and related health complications. As the
  population ages, there is a greater need for
  effective obesity management strategies,
  including pharmacological interventions.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/united-states-obesity-d
  rugs-market

5
Report Segmentation

• Breakup by Type
• Prescription Drugs
• OTC Drugs
•  
• Breakup by Age
• Children
• Adult
• Old
• Breakup by Gender
• Male
• Female
• Breakup by Distribution Channel
• Hospital Pharmacy

6
Report Segmentation

• Retail Pharmacy
• Online
• Breakup by Region
• Northeast
• Midwest
• South
• West

7
Key Questions Answered in the Report
8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4 United
  States Obesity Drugs Market - Introduction
• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence
• 5 United States Obesity Drugs Market Landscape
• 5.1 Historical and Current Market Trends
  (2018-2023)
• 5.2 Market Forecast (2024-2032)
• 6 United States Obesity Drugs Market - Breakup
  by Type
• 6.1 Prescription Drugs
• 6.1.1 Overview
• 6.1.2 Historical and Current Market
  Trends (2018-2023)
• 6.1.3 Market Forecast (2024-2032)
• 6.2 OTC Drugs
• 6.2.1 Overview
• 6.2.2 Historical and Current Market
  Trends (2018-2023)
• 6.2.3 Market Forecast (2024-2032)
• 7 United States Obesity Drugs Market - Breakup
  by Age        

10
Table of Contents

•      7.1    Children        7.1.1 Overview     
    7.1.2 Historical and Current Market Trends
  (2018-2023)        7.1.3 Market Forecast
  (2024-2032)    7.2    Adult        7.2.1
  Overview        7.2.2 Historical and Current
  Market Trends (2018-2023)        7.2.3 Market
  Forecast (2024-2032)    7.3    Old        7.3.1
  Overview        7.3.2 Historical and Current
  Market Trends (2018-2023)        7.3.3 Market
  Forecast (2024-2032)8   United States Obesity
  Drugs Market - Breakup by Gender    8.1  
   Male        8.1.1 Overview        8.1.2
  Historical and Current Market Trends
  (2018-2023)        8.1.3 Market Forecast
  (2024-2032)    8.2    Female        8.2.1
  Overview        8.2.2 Historical and Current
  Market Trends (2018-2023)        8.2.3 Market
  Forecast (2024-2032)9   United States Obesity
  Drugs Market - Breakup by Distribution Channel 
    9.1    Hospital Pharmacy        9.1.1
  Overview        9.1.2 Historical and Current
  Market Trends (2018-2023)        9.1.3 Market
  Forecast (2024-2032)    9.2    Retail Pharmacy 
        9.2.1 Overview
• For more information, visit https//www.imarcgrou
  p.com/united-states-obesity-drugs-market/toc

11
Partial List of Clients
12
Partial List of Clients
13
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

14
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us